✦ LIBER ✦

Recombinant interferon-alfa therapy in children with chronic hepatitis C

✍ Scribed by Flavia Bortolotti; Raffaella Giacchino; Pietro Vajro; Cristiana Barbera; Carlo Crivellaro; Alfredo Alberti; Gabriella Nebbia; Lucia Zancan; Lorena de Moliner; Adalberto Bertolini; Fiorella Balli; Francesco Callea

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 642 KB
Volume: 22
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840220602

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breakthrough during recombinant interfer

Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: Prevalence, etiology, and management

✍ Luigi Roffi; Guido Colloredo Mels; Guido Antonelli; Giorgio Bellati; Fabio Paniz 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 567 KB

Recombinant interferon alfa (r-IFNa2) has been shown to normalize the aminotransferase levels in approximately 50% of patients with chronic hepatitis C virus (HCV). Few patients experience a relapse during the treatment, in spite of a complete initial response (breakthrough). We studied 191 HCV Ab-p

Re-treatment with interferon alfa of pat

Re-treatment with interferon alfa of patients with chronic hepatitis C

✍ Wan-Cheng Chow; Nathalie Boyer; Michele Pouteau; Corinne Castelnau; Michele Mart 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Treatment of patients with chronic hepatitis C has had limited success because of relapses and nonresponse to interferon alfa therapy (currently the only established therapeutic agent). A retrospective study was done to determine the efficacy of re-treatment with interferon and the predictors of res

Treatment of children with chronic hepat

Treatment of children with chronic hepatitis C with recombinant interferon-α: A pilot study

✍ Mercedes Ruiz-Moreno; Maria José Rua; Inmaculada Castillo; Maria Dolores García- 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 1 views

Twelve children with chronic non-A, non-B hepatitis were entered in a pilot trial of recombinant interferon-alpha. Although all the children had hepatitis C virus RNA in serum, only five had antibodies against this virus. Children received 3 MU/m2 body surface area interferon-alpha 3 times/wk for 6

Predictors of a sustained beneficial res

Predictors of a sustained beneficial response to interferon alfa therapy in chronic hepatitis C

✍ Hari S. Conjeevaram; James E. Everhart; Jay H. Hoofnagle 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB 👁 2 views

## Predictors of a Sustained Beneficial Response to Interferon Alfa Therapy in Chronic Hepatitis C Interferon alfa was first reported to have beneficial effects in chronic hepatitis C in the mid-l980s,' effects that were subsequently verified in multiple randomized controlled trials performed in

A prospective, randomized trial comparin

A prospective, randomized trial comparing lymphoblastoid to recombinant interferon alfa 2a as therapy for chronic hepatitis C

✍ M Rumi; E Del Ninno; M L Parravicini; R Romeo; R Soffredini; M F Donato; J Wilbe 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 1 views

r-interferon alfa–2b/ribavirin combined

r-interferon alfa–2b/ribavirin combined therapy followed by low-dose r-Interferon alfa-2b in chronic hepatitis C interferon nonresponders

✍ A. Perasso; G. Testino; F. Ansaldi; V. Venturino; G.C. Icardi 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 2 views